Assessment of long-term survival in childhood cancer patients using cancer registry data from eastern China: period analysis outperforms traditional analysis

This study systematically evaluated whether period analysis outperforms traditional cohort and complete analyses in estimating 5-year relative survival (RS) for childhood cancer patients using data from nine cancer registries in Taizhou, Eastern China (2009-2018). Analyses included patients under 15...

Full description

Saved in:
Bibliographic Details
Main Authors: Bing, Xin (Author) , Lei, Qiqi (Author) , Wang, Liangyou (Author) , Zhao, Xiaojiao (Author) , Chen, Xukai (Author) , Zhang, Luyao (Author) , Försti, Asta (Author) , Yang, Jun (Author) , Chen, Tianhui (Author)
Format: Article (Journal)
Language:English
Published: 15 December 2025
In: International journal of cancer
Year: 2025, Volume: 157, Issue: 12, Pages: 2476-2484
ISSN:1097-0215
DOI:10.1002/ijc.70060
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ijc.70060
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.70060
Get full text
Author Notes:Xin Bing, Qiqi Lei, Liangyou Wang, Xiaojiao Zhao, Xukai Chen, Luyao Zhang, Asta Försti, Jun Yang, Tianhui Chen
Description
Summary:This study systematically evaluated whether period analysis outperforms traditional cohort and complete analyses in estimating 5-year relative survival (RS) for childhood cancer patients using data from nine cancer registries in Taizhou, Eastern China (2009-2018). Analyses included patients under 15 years diagnosed with childhood cancers, with 5-year RS estimates from cohort, complete, and period methods compared against observed actual survival (2014-2018: 70.1%). Accuracy and robustness were assessed via deviation value (DV) and standard error (SE). Cohort analysis yielded a 5-year RS of 55.8% (DV: −14.3%, SE: 2.4), complete analysis 61.1% (DV: −9.0%, SE: 1.7), and period analysis 68.2% (DV: −1.9%, SE: 2.1). Stratified evaluations by sex, region, age at diagnosis, and cancer types confirmed period analysis as the most accurate (lowest DV across subgroups) while complete analysis showed the smallest SE values, indicating superior robustness. Cohort analysis performed the worst in both accuracy and robustness. This study is the first in China to validate that period analysis offers superior accuracy in estimating 5-year RS for childhood cancer patients overall and across various stratifications compared to cohort and complete analyses. Findings underscore the utility of period analysis in generating timely survival estimates to inform early detection strategies and cancer control policies, offering critical methodological support for advancing pediatric oncology outcomes assessment in China.
Item Description:Zuerst veröffentlicht: 23. Juli 2025
Gesehen am 26.11.2025
Physical Description:Online Resource
ISSN:1097-0215
DOI:10.1002/ijc.70060